With regards to the tumor-expressed panel, hsa-mir-183 regulates the PI3K/AKT signaling pathway, exerting its oncogenic activity through PTEN inhibition, interfering with the cell cycle, BRCA cell proliferation, and migration. Here, PTEN is linked to neoplasm.